نتائج البحث - Sevil Korkmaz‐Icöz

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus

    The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus حسب Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, László Hidi, Ede Birtalan, Dalma Kellermayer, Mihály Ruppert, Sevil Korkmaz‐Icöz, Gábor Kökény, E Horváth, Gábor Szabó, Béla Merkely, Tamás Radovits

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation

    Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation حسب Alex Ali Sayour, Sevil Korkmaz‐Icöz, Sivakkanan Loganathan, Mihály Ruppert, Nabil V. Sayour, Attila Oláh, Kálmán Benke, Maik Brune, Rita Benkő, E Horváth, Matthias Karck, Béla Merkely, Tamás Radovits, Gábor Szabó

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Critical role of RAGE and HMGB1 in inflammatory heart disease

    Critical role of RAGE and HMGB1 in inflammatory heart disease حسب Anna Bangert, Martin Andrassy, Anna‐Maria Müller, Mariella Bockstahler, Andrea Fischer, Christian Volz, Christoph Leib, Stefan Göser, Sevil Korkmaz‐Icöz, Stefan Zittrich, Andreas Jungmann, Felix Lasitschka, Gabriele Pfitzer, Oliver J. Müller, Hugo A. Katus, Ziya Kaya

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: